Geneva, Nov. 3 -- International Clinical Trials Registry received information related to the study (NCT06373263) titled 'Evaluating Tools to Communicate Scleroderma Research Results to Patients - Trial #1' on April 15, 2024.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Other. Masking: None (Open Label).
Primary Sponsor: Lady Davis Institute
Condition:
Scleroderma
Systemic Sclerosis
Intervention:
Other: Plain-language summary
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: December 2025
Target Sample Size: 128
To know more, visit https://clinicaltrials.gov/study/NCT06373263
Published by HT Digital Content Services with pe...